Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

GSK holding history

GSK plc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
151,573
Value
$7.95M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of GSK by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026151,573$7.95M<0.1%+151,573NewHolders
Q1 20260$00.0%−214,099−100.0%Sold outHolders
Q4 2025214,099$10.5M<0.1%+214,099NewHolders
Q3 20250$00.0%−121,685−100.0%Sold outHolders
Q2 2025121,685$4.67M<0.1%−1,501,889−92.5%ReducedHolders
Q1 20251,623,574$62.9M0.1%+1,439,760+783.3%AddedHolders
Q4 2024183,814$6.22M<0.1%−393,225−68.1%ReducedHolders
Q3 2024577,039$23.6M<0.1%+563,210+4,072.7%AddedHolders
Q2 202413,829$532.4K<0.1%−203,555−93.6%ReducedHolders
Q1 2024217,384$9.32M<0.1%+99,049+83.7%AddedHolders
Q4 2023118,335$4.39M<0.1%−414,275−77.8%ReducedHolders
Q3 2023532,610$19.3M<0.1%+505,088+1,835.2%AddedHolders
Q2 202327,522$980.9K<0.1%−250,135−90.1%ReducedHolders
Q1 2023277,657$9.88M<0.1%−655,824−70.3%ReducedHolders
Q4 2022933,481$32.8M<0.1%−2,778,462−74.9%ReducedHolders
Q3 20223,711,943$109.2M0.1%+2,372,734+177.2%AddedHolders
Q2 20221,339,209$58.3M0.1%+152,088+12.8%AddedHolders
Q1 20221,187,121$51.7M0.1%+177,586+17.6%AddedHolders
Q4 20211,009,535$44.5M<0.1%+513,369+103.5%AddedHolders
Q3 2021496,166$19.0M<0.1%−170,695−25.6%ReducedHolders
Q2 2021666,861$26.6M<0.1%−441,582−39.8%ReducedHolders
Q1 20211,108,443$39.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.